| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of rDNA heterochromatin formation | 6.99e-06 | 3 | 32 | 2 | GO:0061187 | |
| GeneOntologyBiologicalProcess | ERBB2-EGFR signaling pathway | 6.49e-05 | 8 | 32 | 2 | GO:0038134 | |
| GeneOntologyBiologicalProcess | detection of visible light | 9.38e-05 | 57 | 32 | 3 | GO:0009584 | |
| GeneOntologyBiologicalProcess | rDNA heterochromatin formation | 1.04e-04 | 10 | 32 | 2 | GO:0000183 | |
| GeneOntologyBiologicalProcess | regulation of opsin-mediated signaling pathway | 1.04e-04 | 10 | 32 | 2 | GO:0022400 | |
| GeneOntologyBiologicalProcess | nucleolar chromatin organization | 1.27e-04 | 11 | 32 | 2 | GO:1990700 | |
| GeneOntologyBiologicalProcess | G protein-coupled opsin signaling pathway | 1.80e-04 | 13 | 32 | 2 | GO:0016056 | |
| GeneOntologyBiologicalProcess | detection of light stimulus | 2.30e-04 | 77 | 32 | 3 | GO:0009583 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 4.31e-04 | 231 | 32 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | phototransduction, visible light | 4.35e-04 | 20 | 32 | 2 | GO:0007603 | |
| GeneOntologyBiologicalProcess | nucleolus organization | 4.81e-04 | 21 | 32 | 2 | GO:0007000 | |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 6.30e-04 | 24 | 32 | 2 | GO:0031445 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 7.99e-04 | 27 | 32 | 2 | GO:0038128 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 8.29e-04 | 275 | 32 | 4 | GO:0016072 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 9.22e-04 | 29 | 32 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | cellular response to light stimulus | 1.06e-03 | 130 | 32 | 3 | GO:0071482 | |
| Domain | EGF_rcpt_ligand | 4.25e-05 | 6 | 32 | 2 | IPR015497 | |
| Domain | AAA | 1.54e-03 | 34 | 32 | 2 | PS00674 | |
| Domain | AAA | 3.57e-03 | 52 | 32 | 2 | PF00004 | |
| Domain | ATPase_AAA_core | 3.85e-03 | 54 | 32 | 2 | IPR003959 | |
| Domain | Zinc_finger_PHD-type_CS | 5.53e-03 | 65 | 32 | 2 | IPR019786 | |
| Domain | PHD | 7.30e-03 | 75 | 32 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 8.07e-03 | 79 | 32 | 2 | IPR019787 | |
| Domain | IQ | 8.47e-03 | 81 | 32 | 2 | SM00015 | |
| Domain | PHD | 1.01e-02 | 89 | 32 | 2 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 1.04e-02 | 90 | 32 | 2 | IPR000048 | |
| Domain | Znf_PHD | 1.06e-02 | 91 | 32 | 2 | IPR001965 | |
| Domain | IQ | 1.10e-02 | 93 | 32 | 2 | PS50096 | |
| Domain | ZF_PHD_2 | 1.15e-02 | 95 | 32 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.17e-02 | 96 | 32 | 2 | PS01359 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 1.66e-05 | 34 | 21 | 3 | M27183 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 7.56e-05 | 9 | 21 | 2 | MM14853 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 7.56e-05 | 9 | 21 | 2 | M27133 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 1.63e-04 | 13 | 21 | 2 | MM14701 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 1.90e-04 | 14 | 21 | 2 | M719 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M201 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.80e-04 | 220 | 21 | 4 | M27794 | |
| Pathway | REACTOME_GAB1_SIGNALOSOME | 2.84e-04 | 17 | 21 | 2 | MM14700 | |
| Pathway | REACTOME_GAB1_SIGNALOSOME | 2.84e-04 | 17 | 21 | 2 | M10450 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 4.20e-04 | 100 | 21 | 3 | M27158 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 5.72e-04 | 24 | 21 | 2 | M27952 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | 6.21e-04 | 25 | 21 | 2 | M563 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 8.60e-04 | 296 | 21 | 4 | M27869 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 9.58e-04 | 31 | 21 | 2 | MM14705 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 9.58e-04 | 31 | 21 | 2 | MM14896 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 9.58e-04 | 31 | 21 | 2 | M16597 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 9.64e-04 | 133 | 21 | 3 | MM15529 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 2.10e-03 | 46 | 21 | 2 | MM15950 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 2.38e-03 | 49 | 21 | 2 | MM14695 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 2.72e-03 | 191 | 21 | 3 | MM15586 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 2.78e-03 | 53 | 21 | 2 | M27039 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 3.44e-03 | 59 | 21 | 2 | M48104 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.05e-08 | 608 | 32 | 8 | 36089195 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.35e-07 | 954 | 32 | 9 | 36373674 | |
| Pubmed | CYLC1 SRP72 HMGN2 MACROH2A1 GTF3C1 STAG2 CHD5 BAHCC1 BBOF1 NGDN | 4.07e-07 | 1442 | 32 | 10 | 35575683 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19609315 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16470170 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 17960400 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 11518516 | ||
| Pubmed | TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. | 4.92e-06 | 4 | 32 | 2 | 12743035 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 23427265 | ||
| Pubmed | Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus. | 4.92e-06 | 4 | 32 | 2 | 8592515 | |
| Pubmed | Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. | 8.19e-06 | 5 | 32 | 2 | 17525275 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 12568494 | ||
| Pubmed | 1.00e-05 | 317 | 32 | 5 | 30997501 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 18436796 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 8787743 | ||
| Pubmed | 1.37e-05 | 159 | 32 | 4 | 34537242 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.70e-05 | 1294 | 32 | 8 | 30804502 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 24825892 | ||
| Pubmed | 2.58e-05 | 1371 | 32 | 8 | 36244648 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 18069687 | ||
| Pubmed | 3.12e-05 | 1014 | 32 | 7 | 32416067 | ||
| Pubmed | 3.47e-05 | 1429 | 32 | 8 | 35140242 | ||
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 17962208 | ||
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 7590736 | ||
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 8702723 | ||
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 10803598 | ||
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 19474150 | ||
| Pubmed | 4.80e-05 | 731 | 32 | 6 | 29298432 | ||
| Pubmed | 5.32e-05 | 1103 | 32 | 7 | 34189442 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.91e-05 | 759 | 32 | 6 | 35915203 | |
| Pubmed | An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. | 6.36e-05 | 13 | 32 | 2 | 21512138 | |
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 12050136 | ||
| Pubmed | 7.48e-05 | 483 | 32 | 5 | 36912080 | ||
| Pubmed | 1.18e-04 | 103 | 32 | 3 | 32744500 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.21e-04 | 1257 | 32 | 7 | 36526897 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.31e-04 | 877 | 32 | 6 | 20211142 | |
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 12878679 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.62e-04 | 1318 | 32 | 7 | 30463901 | |
| Pubmed | Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis. | 1.70e-04 | 21 | 32 | 2 | 19710174 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 2.01e-04 | 949 | 32 | 6 | 36574265 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.14e-04 | 605 | 32 | 5 | 28977666 | |
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 24043783 | ||
| Pubmed | 2.37e-04 | 332 | 32 | 4 | 25693804 | ||
| Pubmed | 2.57e-04 | 339 | 32 | 4 | 30415952 | ||
| Pubmed | 2.60e-04 | 340 | 32 | 4 | 29478914 | ||
| Pubmed | 2.84e-04 | 27 | 32 | 2 | 36915679 | ||
| Pubmed | 3.04e-04 | 653 | 32 | 5 | 22586326 | ||
| Pubmed | 3.38e-04 | 1487 | 32 | 7 | 33957083 | ||
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 3.56e-04 | 150 | 32 | 3 | 30154076 | |
| Pubmed | Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein. | 3.75e-04 | 31 | 32 | 2 | 37939376 | |
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 3.75e-04 | 31 | 32 | 2 | 23602572 | |
| Pubmed | 3.99e-04 | 156 | 32 | 3 | 37108203 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.05e-04 | 1082 | 32 | 6 | 38697112 | |
| Pubmed | 4.49e-04 | 711 | 32 | 5 | 33022573 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.54e-04 | 394 | 32 | 4 | 27248496 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 5.13e-04 | 170 | 32 | 3 | 16159877 | |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 5.35e-04 | 37 | 32 | 2 | 36835656 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 5.86e-04 | 754 | 32 | 5 | 33060197 | |
| Pubmed | 6.58e-04 | 41 | 32 | 2 | 21052544 | ||
| Pubmed | 6.87e-04 | 188 | 32 | 3 | 29721183 | ||
| Pubmed | Mapping of transcription start sites of human retina expressed genes. | 7.92e-04 | 45 | 32 | 2 | 17286855 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 7.95e-04 | 807 | 32 | 5 | 22681889 | |
| Pubmed | 8.82e-04 | 205 | 32 | 3 | 28927264 | ||
| Interaction | H3-3A interactions | ZNF512B NVL PHF2 MACROH2A1 UBN1 GTF3C1 METAP2 RPS3A STAG2 CHD5 | 1.45e-07 | 749 | 32 | 10 | int:H3-3A |
| Interaction | ZNF330 interactions | 3.57e-07 | 446 | 32 | 8 | int:ZNF330 | |
| Interaction | RPL31 interactions | 7.52e-07 | 680 | 32 | 9 | int:RPL31 | |
| Interaction | RPS24 interactions | 1.29e-06 | 529 | 32 | 8 | int:RPS24 | |
| Interaction | CENPA interactions | 1.71e-06 | 377 | 32 | 7 | int:CENPA | |
| Interaction | ASF1A interactions | 2.32e-06 | 249 | 32 | 6 | int:ASF1A | |
| Interaction | H2BC8 interactions | 2.43e-06 | 576 | 32 | 8 | int:H2BC8 | |
| Interaction | RPL13A interactions | 2.95e-06 | 591 | 32 | 8 | int:RPL13A | |
| Interaction | RPL11 interactions | 6.08e-06 | 652 | 32 | 8 | int:RPL11 | |
| Interaction | H2BC12 interactions | 1.01e-05 | 322 | 32 | 6 | int:H2BC12 | |
| Interaction | RPL3 interactions | 1.28e-05 | 722 | 32 | 8 | int:RPL3 | |
| Interaction | SMC5 interactions | 1.75e-05 | 1000 | 32 | 9 | int:SMC5 | |
| Interaction | RPL4 interactions | 1.93e-05 | 764 | 32 | 8 | int:RPL4 | |
| Interaction | HNRNPU interactions | 2.31e-05 | 1035 | 32 | 9 | int:HNRNPU | |
| Interaction | NCL interactions | 2.63e-05 | 798 | 32 | 8 | int:NCL | |
| Interaction | H2AC17 interactions | 3.03e-05 | 232 | 32 | 5 | int:H2AC17 | |
| Interaction | RPL23A interactions | 3.75e-05 | 606 | 32 | 7 | int:RPL23A | |
| Interaction | RPL5 interactions | 3.75e-05 | 606 | 32 | 7 | int:RPL5 | |
| Interaction | H2BC4 interactions | 5.11e-05 | 259 | 32 | 5 | int:H2BC4 | |
| Interaction | RPS19 interactions | 5.26e-05 | 639 | 32 | 7 | int:RPS19 | |
| Interaction | SUZ12 interactions | 5.52e-05 | 644 | 32 | 7 | int:SUZ12 | |
| Interaction | H3C1 interactions | 6.24e-05 | 901 | 32 | 8 | int:H3C1 | |
| Interaction | RPLP0 interactions | 6.45e-05 | 660 | 32 | 7 | int:RPLP0 | |
| Interaction | H3-4 interactions | 6.47e-05 | 448 | 32 | 6 | int:H3-4 | |
| Interaction | POLR1G interactions | 1.05e-04 | 489 | 32 | 6 | int:POLR1G | |
| Interaction | CDC14B interactions | 1.10e-04 | 158 | 32 | 4 | int:CDC14B | |
| Interaction | H3C3 interactions | 1.12e-04 | 495 | 32 | 6 | int:H3C3 | |
| Interaction | APEX1 interactions | ZNF512B PHF2 HMGN2 GTF2F1 MACROH2A1 EPS8L2 GTF3C1 METAP2 STAG2 | 1.15e-04 | 1271 | 32 | 9 | int:APEX1 |
| Interaction | MECP2 interactions | 1.26e-04 | 1287 | 32 | 9 | int:MECP2 | |
| Interaction | RPL18 interactions | 1.35e-04 | 512 | 32 | 6 | int:RPL18 | |
| Interaction | PARP1 interactions | 1.49e-04 | 1316 | 32 | 9 | int:PARP1 | |
| Interaction | CHD3 interactions | 1.52e-04 | 757 | 32 | 7 | int:CHD3 | |
| Interaction | WDR46 interactions | 1.56e-04 | 173 | 32 | 4 | int:WDR46 | |
| Interaction | RPL15 interactions | 1.63e-04 | 530 | 32 | 6 | int:RPL15 | |
| Interaction | RPL14 interactions | 2.07e-04 | 554 | 32 | 6 | int:RPL14 | |
| Interaction | POLR1E interactions | 2.10e-04 | 350 | 32 | 5 | int:POLR1E | |
| Interaction | ZMYND8 interactions | 2.28e-04 | 191 | 32 | 4 | int:ZMYND8 | |
| Interaction | RPL17 interactions | 2.44e-04 | 571 | 32 | 6 | int:RPL17 | |
| Interaction | RPS6 interactions | 3.66e-04 | 874 | 32 | 7 | int:RPS6 | |
| Interaction | H2BC3 interactions | 4.16e-04 | 406 | 32 | 5 | int:H2BC3 | |
| Interaction | RPL6 interactions | 4.38e-04 | 637 | 32 | 6 | int:RPL6 | |
| Interaction | CBX3 interactions | 4.71e-04 | 646 | 32 | 6 | int:CBX3 | |
| Interaction | RPS8 interactions | 4.83e-04 | 649 | 32 | 6 | int:RPS8 | |
| Interaction | ABT1 interactions | 5.02e-04 | 423 | 32 | 5 | int:ABT1 | |
| Interaction | RPL26L1 interactions | 5.47e-04 | 431 | 32 | 5 | int:RPL26L1 | |
| Interaction | RPL27 interactions | 5.47e-04 | 431 | 32 | 5 | int:RPL27 | |
| Interaction | NIFK interactions | 5.47e-04 | 431 | 32 | 5 | int:NIFK | |
| Interaction | GTF3C1 interactions | 5.51e-04 | 241 | 32 | 4 | int:GTF3C1 | |
| Interaction | MTA2 interactions | 5.70e-04 | 435 | 32 | 5 | int:MTA2 | |
| Interaction | KDM2A interactions | 5.77e-04 | 103 | 32 | 3 | int:KDM2A | |
| Interaction | RPL22 interactions | 6.00e-04 | 440 | 32 | 5 | int:RPL22 | |
| Interaction | KIF21A interactions | 6.11e-04 | 105 | 32 | 3 | int:KIF21A | |
| Interaction | RPL7A interactions | 6.13e-04 | 679 | 32 | 6 | int:RPL7A | |
| Interaction | RPL13 interactions | 7.19e-04 | 700 | 32 | 6 | int:RPL13 | |
| Interaction | CCDC124 interactions | 7.76e-04 | 114 | 32 | 3 | int:CCDC124 | |
| Interaction | NEIL1 interactions | 9.15e-04 | 276 | 32 | 4 | int:NEIL1 | |
| Interaction | ADARB1 interactions | 9.66e-04 | 489 | 32 | 5 | int:ADARB1 | |
| Interaction | MTA1 interactions | 1.00e-03 | 283 | 32 | 4 | int:MTA1 | |
| Interaction | RPL28 interactions | 1.01e-03 | 494 | 32 | 5 | int:RPL28 | |
| Interaction | AURKAIP1 interactions | 1.02e-03 | 284 | 32 | 4 | int:AURKAIP1 | |
| Interaction | RPL34 interactions | 1.03e-03 | 285 | 32 | 4 | int:RPL34 | |
| Interaction | SRSF6 interactions | 1.10e-03 | 503 | 32 | 5 | int:SRSF6 | |
| Interaction | NRDC interactions | 1.11e-03 | 129 | 32 | 3 | int:NRDC | |
| Interaction | H2AC4 interactions | 1.12e-03 | 506 | 32 | 5 | int:H2AC4 | |
| Interaction | RBBP7 interactions | 1.13e-03 | 507 | 32 | 5 | int:RBBP7 | |
| Interaction | MBD3 interactions | 1.17e-03 | 295 | 32 | 4 | int:MBD3 | |
| Interaction | RPS9 interactions | 1.22e-03 | 515 | 32 | 5 | int:RPS9 | |
| Interaction | ZCRB1 interactions | 1.24e-03 | 134 | 32 | 3 | int:ZCRB1 | |
| Interaction | LOC102724334 interactions | 1.24e-03 | 134 | 32 | 3 | int:LOC102724334 | |
| Interaction | NR2C2 interactions | 1.26e-03 | 1403 | 32 | 8 | int:NR2C2 | |
| Interaction | FOXB1 interactions | 1.26e-03 | 135 | 32 | 3 | int:FOXB1 | |
| Interaction | TOP2A interactions | 1.27e-03 | 520 | 32 | 5 | int:TOP2A | |
| Interaction | RPS14 interactions | 1.37e-03 | 529 | 32 | 5 | int:RPS14 | |
| Interaction | DHX29 interactions | 1.43e-03 | 141 | 32 | 3 | int:DHX29 | |
| Interaction | ANOS1 interactions | 1.49e-03 | 143 | 32 | 3 | int:ANOS1 | |
| Interaction | H2AC14 interactions | 1.52e-03 | 144 | 32 | 3 | int:H2AC14 | |
| Interaction | H2BC15 interactions | 1.52e-03 | 144 | 32 | 3 | int:H2BC15 | |
| Interaction | EED interactions | 1.52e-03 | 1445 | 32 | 8 | int:EED | |
| Interaction | TOX3 interactions | 1.57e-03 | 37 | 32 | 2 | int:TOX3 | |
| Interaction | CHN1 interactions | 1.57e-03 | 37 | 32 | 2 | int:CHN1 | |
| GeneFamily | Dynein regulatory complex | 6.36e-05 | 11 | 20 | 2 | 981 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 3.43e-04 | 25 | 20 | 2 | 565 | |
| GeneFamily | AAA ATPases | 1.55e-03 | 53 | 20 | 2 | 413 | |
| GeneFamily | PHD finger proteins | 4.39e-03 | 90 | 20 | 2 | 88 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 3.99e-06 | 198 | 32 | 5 | M3195 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.24e-05 | 200 | 32 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.24e-05 | 200 | 32 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.52e-04 | 145 | 32 | 3 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 2.03e-04 | 160 | 32 | 3 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 2.03e-04 | 160 | 32 | 3 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TEM|URO / Disease, Lineage and Cell Type | 2.03e-04 | 160 | 32 | 3 | e406f77b1c1a01d74f39ba65f99d5f8c7d75faf1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 2.26e-04 | 166 | 32 | 3 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 2.26e-04 | 166 | 32 | 3 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 2.26e-04 | 166 | 32 | 3 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 2.30e-04 | 167 | 32 | 3 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-04 | 168 | 32 | 3 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.38e-04 | 169 | 32 | 3 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.38e-04 | 169 | 32 | 3 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-04 | 174 | 32 | 3 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-04 | 174 | 32 | 3 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.60e-04 | 174 | 32 | 3 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 176 | 32 | 3 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 177 | 32 | 3 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 177 | 32 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 179 | 32 | 3 | fc9f44fb81da0d381a5141a95a005e66a0be28cc | |
| ToppCell | facs-Bladder-nan-24m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 179 | 32 | 3 | 9152d92bb96e65d43de54e933494f0d08ae02c4f | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 268fc48ffd88e19c9dcd1af32b635256fc915742 | |
| ToppCell | CV-Moderate-4|CV / Virus stimulation, Condition and Cluster | 3.06e-04 | 184 | 32 | 3 | 90f5b447064743246b09a6c47bf561efafa15e1f | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.06e-04 | 184 | 32 | 3 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.06e-04 | 184 | 32 | 3 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | CV-Moderate-4|Moderate / Virus stimulation, Condition and Cluster | 3.11e-04 | 185 | 32 | 3 | 4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-04 | 186 | 32 | 3 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 8589d55f7f778442bf31cd4eb1fdaa632f1b7ab0 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.21e-04 | 187 | 32 | 3 | e5713a7bda53d1d5178ab4e0dbadc2292b6005bc | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | 6288da8cdd450c58df00ebcfcc118f01fab7e610 | |
| ToppCell | CD8+_Memory_T_cell-CV-4|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.21e-04 | 187 | 32 | 3 | 9c2fc2f259fa7d3a65fb99c295ac378e03d9aa6c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 188 | 32 | 3 | 9a10536afa2dea34c78421d36564cfd8252afe45 | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.31e-04 | 189 | 32 | 3 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 3.36e-04 | 190 | 32 | 3 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.36e-04 | 190 | 32 | 3 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.41e-04 | 191 | 32 | 3 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 191 | 32 | 3 | dad675251e129254955eac179c84a641a4864586 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 47066fda0eb1576023c1906584713d1b03e2303c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 191 | 32 | 3 | 6d2cf41ee946137c039ddcc13593fc3f670afbba | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.41e-04 | 191 | 32 | 3 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.46e-04 | 192 | 32 | 3 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.46e-04 | 192 | 32 | 3 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | ASK454-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.46e-04 | 192 | 32 | 3 | 01e6324146ea34785b770231b40f7a18f128f526 | |
| ToppCell | facs-Lung-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-04 | 192 | 32 | 3 | ebfd8209a7353fbccb8ca7ade14b4f25822cebd2 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.46e-04 | 192 | 32 | 3 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | ASK454-Immune-Mast_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.46e-04 | 192 | 32 | 3 | 4ab2524cce70b6a3a3dd31085b421565a7406c56 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 9d7bc71c4ae871aad057d3beb6e06c929ae17203 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.52e-04 | 193 | 32 | 3 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 66dd5ea1f9ea4b6160a0b79b068a421754689312 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.57e-04 | 194 | 32 | 3 | 8805c90e4284a81a6c8078f2d2417ae77b4e5c63 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-04 | 194 | 32 | 3 | 86d52467b05a0018517377c9c441245501f71d91 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.57e-04 | 194 | 32 | 3 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-04 | 194 | 32 | 3 | c53478057674d70b79df8a3f476d15dea1925753 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.57e-04 | 194 | 32 | 3 | 2ab3f75b795a0ee4fe0f8eeba33093fcc77935f5 | |
| ToppCell | IIF-Myeloid-cDC|IIF / Disease, Lineage and Cell Type | 3.62e-04 | 195 | 32 | 3 | 81225852a5827e973cb3b1da5c41e93d5407ecb6 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM5|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.62e-04 | 195 | 32 | 3 | 6d768454ed630e586431535400507074eea76dd1 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.62e-04 | 195 | 32 | 3 | 79fd13a7dd9f07f86bcab280c0be1899a692fab2 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.62e-04 | 195 | 32 | 3 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.62e-04 | 195 | 32 | 3 | 7fb5c0911ff09580515d1a1827d7249d6242630c | |
| ToppCell | myeloid-cDC|World / Lineage and Cell class | 3.68e-04 | 196 | 32 | 3 | 60258111945ee823f325bff032049c60377206d1 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.68e-04 | 196 | 32 | 3 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | ILEUM-inflamed-(3)_DC2|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.68e-04 | 196 | 32 | 3 | 0a7f77ed4ea3afdd9ad8a2d2c5df83778be5197b | |
| ToppCell | control-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.68e-04 | 196 | 32 | 3 | 25994ca143701c72d2f84a3b6d348fcfa1d26a54 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 196 | 32 | 3 | 00f9171da4c791619e8c4c8c3c7da578c96a30ed | |
| ToppCell | Control-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.73e-04 | 197 | 32 | 3 | 925bf0d38e4ce279fa45f455546ebd199282c0df | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 3.79e-04 | 198 | 32 | 3 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.79e-04 | 198 | 32 | 3 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | ILEUM-non-inflamed-(3)_DC2|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.79e-04 | 198 | 32 | 3 | 34157b3ff2c4867cacde38810999fac279051bc8 | |
| ToppCell | distal-Epithelial-Ciliated-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.79e-04 | 198 | 32 | 3 | d30d6c6a0a78b7571318b5b2a0186df96dd0f5a9 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.79e-04 | 198 | 32 | 3 | 2e669da80363163b806f23a645474d482797ae5d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-04 | 199 | 32 | 3 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|Dendritic_cell / Lineage, cell class and subclass | 3.85e-04 | 199 | 32 | 3 | 688fc273c51a957e2e1f2c7d273376bd7971139d | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.85e-04 | 199 | 32 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-04 | 199 | 32 | 3 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-04 | 199 | 32 | 3 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.85e-04 | 199 | 32 | 3 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-04 | 199 | 32 | 3 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-04 | 199 | 32 | 3 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 199 | 32 | 3 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-04 | 199 | 32 | 3 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | distal-1-Epithelial-Ciliated|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-04 | 199 | 32 | 3 | 4120e4a2bc05adebe1e1e9670ed7ea55142eb83d | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-04 | 199 | 32 | 3 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_DC2|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.85e-04 | 199 | 32 | 3 | 64b320a9e4e65071cff77980dbff7e06526819b3 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-04 | 199 | 32 | 3 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Sepsis-ICU-SEP|Sepsis / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | eea2877435b6faac5e6efc5178c34eea453fb29d | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.90e-04 | 200 | 32 | 3 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | c30da72c3581d384b76c95f5989e32a36d783ef3 | |
| ToppCell | MS-IIF-Myeloid-cDC|IIF / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 620a82805619d113182d59740670c9f9b93ee924 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Severe / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 12626d046a3ed8db1c9bd603ada5b97ead93e587 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.90e-04 | 200 | 32 | 3 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | distal-1-Hematologic-Natural_Killer|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.90e-04 | 200 | 32 | 3 | 69756eba4b9b6cd5115aa7b76dfc36bb70097993 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | 09bac15df511687ff336c1e7a67d980c6c281f79 | |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 2.07e-04 | 21 | 30 | 2 | DOID:0060036 (implicated_via_orthology) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 7.84e-03 | 131 | 30 | 2 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 7.84e-03 | 131 | 30 | 2 | C4552091 | |
| Disease | Juvenile arthritis | 7.84e-03 | 131 | 30 | 2 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 7.84e-03 | 131 | 30 | 2 | C3714758 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKKKAKGKAKGSLRA | 1751 | Q9P281 | |
| SDKPKRKKKGGKNGK | 121 | P15514 | |
| GVRKKIKGSKDGKKK | 251 | Q8TDI0 | |
| IKGSKDGKKKGKGKK | 256 | Q8TDI0 | |
| DGKKKGKGKKTAGLK | 261 | Q8TDI0 | |
| KDKGKKGKKDKGPKV | 91 | Q8IUX7 | |
| RGKGKAKDKEKGKQK | 426 | Q96DY2 | |
| SKKAGGKKGARKSKK | 146 | O75367 | |
| KEKGMGKKGKKGKFV | 416 | Q9NU02 | |
| MPSKGKDKKKGKSKG | 1 | Q8ND07 | |
| RPVKAGKKKDKKGKK | 461 | Q86XH1 | |
| GKLKNKGSKRKKEDL | 221 | O15381 | |
| DGDGATGKKKKKKKK | 91 | P50579 | |
| GYLGAKKKKKKQKRK | 41 | O60551 | |
| AKKGEKVPKGKKGKA | 46 | P05204 | |
| KGDSKKGKKDEKKGK | 451 | P35663 | |
| RKKGKKKGKKAPAEG | 286 | Q9H6S3 | |
| GLLKKAKEKGKNKKS | 196 | Q9H1X3 | |
| HGKRKKKGKGLGKKR | 91 | Q99075 | |
| KLDKKRLKKKGGEKM | 221 | Q8WTQ7 | |
| VKLPKGKRKKKGRKS | 226 | Q9ULF5 | |
| KKLRGKEKPKKGEGK | 86 | Q9Y291 | |
| KKAPLAKGGRKKKKK | 236 | P35269 | |
| AKGGRKKKKKKGSDD | 241 | P35269 | |
| LKLKDGGKKKGKKSR | 521 | O75151 | |
| NKRLTKGGKKGAKKK | 6 | P61247 | |
| KRGKKQLGSLKKKFK | 226 | Q15527 | |
| QGQGDLKKKKKKKKG | 546 | O76094 | |
| KKKQQQKKKKGGKGG | 656 | O76094 | |
| KSNQKGKAKGKGKKK | 261 | O00294 | |
| GKAKGKGKKKAKEER | 266 | O00294 | |
| KKRKKIPQKGRKKKG | 296 | Q8NEJ9 | |
| KTCKKGKKGPAEKGK | 41 | Q8N3U4 | |
| GGRGKGKGKKKGKVK | 426 | Q7Z4N2 | |
| KKEKKKNLAGGKKRG | 831 | Q96KM6 | |
| RKLKEGGEKIKKKKK | 191 | Q9NPG3 | |
| KKDPGKKIKRKKKGE | 1221 | Q12789 | |
| KKIKRKKKGEFPGEK | 1226 | Q12789 |